Overall Survival With Ribociclib Plus Letrozole in Advanced Breast Cancer

Gabriel N. Hortobagyi; Salomon M. Stemmer; Howard A. Burris; Yoon Sim Yap; Gabe S. Sonke; Lowell Hart; Mario Campone; Katarina Petrakova; Eric P. Winer; Wolfgang Janni; Pierfranco Conte; David A Cameron; Fabrice André; Carlos L Arteaga; Juan Pablo Zarate; Arunava Chakravartty; Tetiana Taran; Fabienne Le Gac; Paolo Serra; Joyce O'Shaughnessy

doi:10.1056/NEJMoa2114663

Overall Survival With Ribociclib Plus Letrozole in Advanced Breast Cancer

Gabriel N. Hortobagyi, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke, Lowell Hart, Mario Campone, Katarina Petrakova, Eric P. Winer, Wolfgang Janni, Pierfranco Conte, David A Cameron, Fabrice André, Carlos L Arteaga, Juan Pablo Zarate, Arunava Chakravartty, Tetiana Taran, Fabienne Le Gac, Paolo Serra, Joyce O'Shaughnessy

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	New England Journal of Medicine
DOIs	https://doi.org/10.1056/NEJMoa2114663
Publication status	Published - 10 Mar 2022

Access to Document

10.1056/NEJMoa2114663

nejmoa2114663
N Engl J Med 2022;386:942-50. DOI: 10.1056/NEJMoa2114663 Copyright © 2022 Massachusetts Medical Society.
Final published version, 600 KB

Cite this

Hortobagyi, G. N., Stemmer, S. M., A. Burris, H., Sim Yap, Y., Sonke, G. S., Hart, L., Campone, M., Petrakova, K., P. Winer, E., Janni, W., Conte, P., Cameron, D. A., André, F., L Arteaga, C., Pablo Zarate, J., Chakravartty, A., Taran, T., Le Gac, F., Serra, P., & O'Shaughnessy, J. (2022). Overall Survival With Ribociclib Plus Letrozole in Advanced Breast Cancer. New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2114663

@article{dd26087399e34a4992cfa952ba95fa2f,

title = "Overall Survival With Ribociclib Plus Letrozole in Advanced Breast Cancer",

author = "Hortobagyi, {Gabriel N.} and Stemmer, {Salomon M.} and {A. Burris}, Howard and {Sim Yap}, Yoon and Sonke, {Gabe S.} and Lowell Hart and Mario Campone and Katarina Petrakova and {P. Winer}, Eric and Wolfgang Janni and Pierfranco Conte and Cameron, {David A} and Fabrice Andr{\'e} and {L Arteaga}, Carlos and {Pablo Zarate}, Juan and Arunava Chakravartty and Tetiana Taran and {Le Gac}, Fabienne and Paolo Serra and Joyce O'Shaughnessy",

note = "Funding Information: Supported by Novartis. Publisher Copyright: Copyright {\textcopyright} 2022 Massachusetts Medical Society.",

year = "2022",

month = mar,

day = "10",

doi = "10.1056/NEJMoa2114663",

language = "English",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOC",

}

Hortobagyi, GN, Stemmer, SM, A. Burris, H, Sim Yap, Y, Sonke, GS, Hart, L, Campone, M, Petrakova, K, P. Winer, E, Janni, W, Conte, P, Cameron, DA, André, F, L Arteaga, C, Pablo Zarate, J, Chakravartty, A, Taran, T, Le Gac, F, Serra, P & O'Shaughnessy, J 2022, 'Overall Survival With Ribociclib Plus Letrozole in Advanced Breast Cancer', New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2114663

TY - JOUR

T1 - Overall Survival With Ribociclib Plus Letrozole in Advanced Breast Cancer

AU - Hortobagyi, Gabriel N.

AU - Stemmer, Salomon M.

AU - A. Burris, Howard

AU - Sim Yap, Yoon

AU - Sonke, Gabe S.

AU - Hart, Lowell

AU - Campone, Mario

AU - Petrakova, Katarina

AU - P. Winer, Eric

AU - Janni, Wolfgang

AU - Conte, Pierfranco

AU - Cameron, David A

AU - André, Fabrice

AU - L Arteaga, Carlos

AU - Pablo Zarate, Juan

AU - Chakravartty, Arunava

AU - Taran, Tetiana

AU - Le Gac, Fabienne

AU - Serra, Paolo

AU - O'Shaughnessy, Joyce

PY - 2022/3/10

Y1 - 2022/3/10

U2 - 10.1056/NEJMoa2114663

DO - 10.1056/NEJMoa2114663

M3 - Article

SN - 0028-4793

JO - New England Journal of Medicine

JF - New England Journal of Medicine

ER -